New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainGiving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce
Oncology January 07,2024
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainGiving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce
Oncology January 07,2024
Does diabetes mean worse outcomes for cancer patients?

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme
Oncology January 07,2024
Does diabetes mean worse outcomes for cancer patients?

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme
Oncology January 07,2024
Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt
Oncology January 07,2024
Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt
Oncology January 07,2024
Global disease burden related to nonmelanoma skin cancer explored

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh
Oncology January 07,2024
Global disease burden related to nonmelanoma skin cancer explored

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh
Oncology January 07,2024
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Oncology January 07,2024
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Oncology January 07,2024
Exploring how gene mutations in tumors impact radiation sensitivity

Exploring how gene mutations in tumors impact radiation sensitivity

byNorthwestern UniversityHigh-content irradiation platform reproducibility for the duration of the profiling effort. The signal-to-noise ratio (SNR), in blue represents the in-plate ratio of rad
Oncology January 07,2024
Exploring how gene mutations in tumors impact radiation sensitivity

Exploring how gene mutations in tumors impact radiation sensitivity

byNorthwestern UniversityHigh-content irradiation platform reproducibility for the duration of the profiling effort. The signal-to-noise ratio (SNR), in blue represents the in-plate ratio of rad
Oncology January 07,2024
Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&
Oncology January 07,2024
Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&
Oncology January 07,2024
Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show
Oncology January 07,2024
Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show
Oncology January 07,2024
Exploring better care for pregnant women with precancerous cervical cancer

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002
Oncology January 07,2024
Exploring better care for pregnant women with precancerous cervical cancer

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002
Oncology January 07,2024
Exploring the biology of 'double positive' T cells

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou
Oncology January 07,2024
Exploring the biology of 'double positive' T cells

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou
Oncology January 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com